Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,769 results for "Product Liability Law & Strategy"...

Practice Tip: Class Actions. Where's the Beef?
June 10, 2013
Despite the fact that product liability class action settlements are subject to judicial scrutiny to ensure substantive and procedural fairness, there is surprisingly little data available regarding how much cash relief class members actually receive post-settlement.
Contacting and Compensating a Non-Party/Former Employee Fact Witness
June 10, 2013
What is the rule for <I>ex parte</I> contact with a corporate adversary's former employee? What you need to know.
Coverage for 'Diminution in Value' in Commercial Property Insurance Policies
June 10, 2013
Cases in numerous states mandate coverage for post-repair diminution of value under automobile policies. But few mandate such coverage under commercial property policies not covering automobiles.
Relearning the Learned Intermediary Doctrine
May 30, 2013
Although the learned intermediary doctrine dictates that a drug manufacturer's duty to warn is owed to the doctor, rather than the patient, informing the doctor of the risks may not always be sufficient to guard against liability.
Practice Tip: Avoiding Federal Jurisdiction in Mass Actions
May 30, 2013
How can a plaintiff overcome the removal of a case by the forum defendant? A look at what needs to be done.
To Call or Not to Call
May 30, 2013
This article briefly examines the controversial topic of ex parte contacts, and describes how such contacts were successfully employed to obtain summary judgment in two separate cases pending within the Aredia'/Zometa' mass tort litigation.
Insurance Coverage for Cyber Attacks
May 30, 2013
Last month, Part One of this article addressed the role of traditional insurance in covering cyber risks. This second installment first continues the discussion of traditional insurance coverages and then addresses specialty "cyber" policies.
In the Courts
May 29, 2013
In-depth analysis of a recent key case.
Drug & Device News
May 28, 2013
Review of the latest news.
Foreseeable Harm to Third Parties Keeps Claim Against Drug Makers Alive
May 28, 2013
Alabama's Supreme Court in January rendered a potentially far-reaching decision in a case pitting a consumer against drug manufacturers. While its holding applies only to cases brought in Alabama, the court's decision may lead to that state's becoming the preferred forum for certain types of drug litigation:

MOST POPULAR STORIES

  • Yachts, Jets, Horses & Hooch: Specialized Commercial Leasing Models
    Defining commercial real estate asset class is essentially a property explaining how it identifies — not necessarily what its original intention was or what others think it ought to be. This article discusses, from a general issue-spot and contextual analysis perspective, how lawyers ought to think about specialized leasing formats and the regulatory backdrops that may inform what the documentation needs to contain for compliance purposes.
    Read More ›
  • Identifying Your Practice's Differentiator
    How to Convey Your Merits In a Way That Earns Trust, Clients and Distinctions Just as no two individuals have the exact same face, no two lawyers practice in their respective fields or serve clients in the exact same way. Think of this as a "Unique Value Proposition." Internal consideration about what you uniquely bring to your clients, colleagues, firm and industry can provide untold benefits for your law practice.
    Read More ›
  • Risks and Ad Fraud Protection In Digital Advertising
    The ever-evolving digital marketing landscape, coupled with the industry-wide adoption of programmatic advertising, poses a significant threat to the effectiveness and integrity of digital advertising campaigns. This article explores various risks to digital advertising from pixel stuffing and ad stacking to domain spoofing and bots. It will also explore what should be done to ensure ad fraud protection and improve effectiveness.
    Read More ›